Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles F Schuler

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Microbiology Spectrum|September 1, 2021
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing AntibodiesCharles F Schuler, Carmen Gherasim, Kelly O'Shea, et al.
The Journal of Allergy and Clinical Immunology. Global|June 1, 2026
The Michigan Sibling Immunity Birth Study (M-SIBS): Study design protocol for a unique food allergy birth cohortKelly M O'Shea, Elizabeth Brooks, Nancy Polmear-Swendris, et al.
The Journal of Allergy and Clinical Immunology|August 1, 2024
Disease heterogeneity and molecular classification of inflammatory palmoplantar diseasesKelsey R van Straalen, Joseph Kirma, Christine M Yee, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Microbiology Spectrum|September 1, 2021
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing AntibodiesCharles F Schuler, Carmen Gherasim, Kelly O'Shea, et al.
The Journal of Allergy and Clinical Immunology. Global|June 1, 2026
The Michigan Sibling Immunity Birth Study (M-SIBS): Study design protocol for a unique food allergy birth cohortKelly M O'Shea, Elizabeth Brooks, Nancy Polmear-Swendris, et al.
The Journal of Allergy and Clinical Immunology|August 1, 2024
Disease heterogeneity and molecular classification of inflammatory palmoplantar diseasesKelsey R van Straalen, Joseph Kirma, Christine M Yee, et al.
Pageof 4